Zon G, Ludeman S M, Sweet E M, Egan W, Phillips L R
J Pharm Sci. 1982 Apr;71(4):443-6. doi: 10.1002/jps.2600710417.
31P- and 1H-NMR spectroscopy were used to demonstrate that the primary metabolites of the anticancer drug cyclophosphamide (4-hydroxycyclophosphamide and its acyclic tautomer, aldophosphamide) are quantitatively converted by O-methylhydroxylamine, at pH 7.4 and 37 degrees, into the E and Z isomers of aldophosphamide O-methyl oxime. These trapping products are readily extracted from aqueous media with either chloroform or ethyl acetate, are stable at pH 6-8 toward oxime hydrolysis and elimination of phosphoramide mustard (a secondary metabolite of cyclophosphamide), and showed no evidence for transoximination with either ketone or aldehyde acceptors. All of these features support the use of aldophosphamide O-methyl oxime in quantitative studies related to cyclophosphamide metabolism.
采用³¹P和¹H核磁共振光谱法证明,在pH 7.4和37℃条件下,抗癌药物环磷酰胺的主要代谢产物(4-羟基环磷酰胺及其无环互变异构体醛磷酰胺)可被O-甲基羟胺定量转化为醛磷酰胺O-甲基肟的E型和Z型异构体。这些捕获产物很容易用氯仿或乙酸乙酯从水介质中萃取出来,在pH 6 - 8时对肟水解和磷酰胺氮芥(环磷酰胺的次要代谢产物)的消除稳定,并且没有证据表明与酮或醛受体发生肟交换反应。所有这些特性都支持醛磷酰胺O-甲基肟在与环磷酰胺代谢相关的定量研究中的应用。